Diagnosis of Alzheimer's disease (AD) is currently largely based on the presence of biomarkers. This may lead to a ...

"We showed people with Alzheimer's disease have more gut inflammation," University of Wisconsin psychologist Barbara Bendlin ...

After some time, early symptomatic Alzheimer's disease begins with a small amount of memory loss and confusion that can be ...

The Alzheimer's disease drug Kisunla will face major reimbursement challenges in the U.K. after the cost-effectiveness ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking ...

Observations show distinct variations between the changes in optic nerve head (ONH) and the macula.

Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...

They discovered that patients who were prescribed semaglutide (the active ingredient in Ozempic and Wegovy) had a "significantly" lower risk of developing Alzheimer’s disease compared to people who ...

The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in ...

The Northeastern New York chapter of the Alzheimer's Association held it's 2024 Walk to End Alzheimer's at the Clark Sports ...

The National Institutes of Health reports that incidences of Alzheimer's disease and other dementia increased by roughly 148 ...